0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Generic Sterile Injectable - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-39R6756
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Generic Sterile Injectable Market Insights and Forecast to 2028
BUY CHAPTERS

Generic Sterile Injectable - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-39R6756
Report
September 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Generic Sterile Injectable - Market Size

The global market for Generic Sterile Injectable was estimated to be worth US$ 51400 million in 2023 and is forecast to a readjusted size of US$ 78570 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Generic Sterile Injectable - Market

Generic Sterile Injectable - Market

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.
The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
An alternative to the oral delivery mechanism is injectable drug delivery, which easily transports a drug dose through the bloodstream, thereby bypassing first-pass metabolism. There are some medications that would be entirely useless if delivered as capsules, as they would be killed by enzymes that digest food in the stomach. The insulin injection used in diabetes care is an example. Insulin is a protein. Therefore, if given as a tablet, the same enzymes that ferment food in the stomach would be digested. Therefore, as of today, there is no such term as an insulin tablet. Injectable allow the transport, directly into the bloodstream, of drugs manufactured in liquid form. The goal of the delivery of injectable drugs is to optimize patient compliance and reduce the frequency of dose administration without reducing medication efficacy. Due to deep vomiting, unconsciousness or having a cancer lining in the upper part of their dietary canal, it may be impossible to take tablets for certain patients. Therefore, injection options are available for most oral medications. The increasing prevalence of such metabolic disease aids in the overall growth in the sterile injectable market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Generic Sterile Injectable, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Generic Sterile Injectable by region & country, by Type, and by Application.
The Generic Sterile Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Sterile Injectable.
Market Segmentation

Scope of Generic Sterile Injectable - Market Report

Report Metric Details
Report Name Generic Sterile Injectable - Market
Forecasted market size in 2030 US$ 78570 million
CAGR 5.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccines
  • Others
Segment by Application
  • Hospitals
  • Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 3M, Baxter Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma, Dr. Reddy’s, Mylan, AstraZeneca Plc, Merck & Co., Inc, Hellberg Safety Ab
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Generic Sterile Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Generic Sterile Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Generic Sterile Injectable in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Generic Sterile Injectable - Market size in 2030?

Ans: The Generic Sterile Injectable - Market size in 2030 will be US$ 78570 million.

Who are the main players in the Generic Sterile Injectable - Market report?

Ans: The main players in the Generic Sterile Injectable - Market are 3M, Baxter Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma, Dr. Reddy’s, Mylan, AstraZeneca Plc, Merck & Co., Inc, Hellberg Safety Ab

What are the Application segmentation covered in the Generic Sterile Injectable - Market report?

Ans: The Applications covered in the Generic Sterile Injectable - Market report are Hospitals, Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Generic Sterile Injectable - Market report?

Ans: The Types covered in the Generic Sterile Injectable - Market report are Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Others

1 Market Overview
1.1 Generic Sterile Injectable Product Introduction
1.2 Global Generic Sterile Injectable Market Size Forecast
1.2.1 Global Generic Sterile Injectable Sales Value (2019-2030)
1.2.2 Global Generic Sterile Injectable Sales Volume (2019-2030)
1.2.3 Global Generic Sterile Injectable Sales Price (2019-2030)
1.3 Generic Sterile Injectable Market Trends & Drivers
1.3.1 Generic Sterile Injectable Industry Trends
1.3.2 Generic Sterile Injectable Market Drivers & Opportunity
1.3.3 Generic Sterile Injectable Market Challenges
1.3.4 Generic Sterile Injectable Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Generic Sterile Injectable Players Revenue Ranking (2023)
2.2 Global Generic Sterile Injectable Revenue by Company (2019-2024)
2.3 Global Generic Sterile Injectable Players Sales Volume Ranking (2023)
2.4 Global Generic Sterile Injectable Sales Volume by Company Players (2019-2024)
2.5 Global Generic Sterile Injectable Average Price by Company (2019-2024)
2.6 Key Manufacturers Generic Sterile Injectable Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Generic Sterile Injectable Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Generic Sterile Injectable
2.9 Generic Sterile Injectable Market Competitive Analysis
2.9.1 Generic Sterile Injectable Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Generic Sterile Injectable Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monoclonal Antibodies
3.1.2 Cytokines
3.1.3 Insulin
3.1.4 Peptide Hormones
3.1.5 Vaccines
3.1.6 Others
3.2 Global Generic Sterile Injectable Sales Value by Type
3.2.1 Global Generic Sterile Injectable Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Generic Sterile Injectable Sales Value, by Type (2019-2030)
3.2.3 Global Generic Sterile Injectable Sales Value, by Type (%) (2019-2030)
3.3 Global Generic Sterile Injectable Sales Volume by Type
3.3.1 Global Generic Sterile Injectable Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Generic Sterile Injectable Sales Volume, by Type (2019-2030)
3.3.3 Global Generic Sterile Injectable Sales Volume, by Type (%) (2019-2030)
3.4 Global Generic Sterile Injectable Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Pharmacies
4.1.3 Online Pharmacies
4.2 Global Generic Sterile Injectable Sales Value by Application
4.2.1 Global Generic Sterile Injectable Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Generic Sterile Injectable Sales Value, by Application (2019-2030)
4.2.3 Global Generic Sterile Injectable Sales Value, by Application (%) (2019-2030)
4.3 Global Generic Sterile Injectable Sales Volume by Application
4.3.1 Global Generic Sterile Injectable Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Generic Sterile Injectable Sales Volume, by Application (2019-2030)
4.3.3 Global Generic Sterile Injectable Sales Volume, by Application (%) (2019-2030)
4.4 Global Generic Sterile Injectable Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Generic Sterile Injectable Sales Value by Region
5.1.1 Global Generic Sterile Injectable Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Generic Sterile Injectable Sales Value by Region (2019-2024)
5.1.3 Global Generic Sterile Injectable Sales Value by Region (2025-2030)
5.1.4 Global Generic Sterile Injectable Sales Value by Region (%), (2019-2030)
5.2 Global Generic Sterile Injectable Sales Volume by Region
5.2.1 Global Generic Sterile Injectable Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Generic Sterile Injectable Sales Volume by Region (2019-2024)
5.2.3 Global Generic Sterile Injectable Sales Volume by Region (2025-2030)
5.2.4 Global Generic Sterile Injectable Sales Volume by Region (%), (2019-2030)
5.3 Global Generic Sterile Injectable Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Generic Sterile Injectable Sales Value, 2019-2030
5.4.2 North America Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Generic Sterile Injectable Sales Value, 2019-2030
5.5.2 Europe Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Generic Sterile Injectable Sales Value, 2019-2030
5.6.2 Asia Pacific Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Generic Sterile Injectable Sales Value, 2019-2030
5.7.2 South America Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Generic Sterile Injectable Sales Value, 2019-2030
5.8.2 Middle East & Africa Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Generic Sterile Injectable Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Generic Sterile Injectable Sales Value
6.2.1 Key Countries/Regions Generic Sterile Injectable Sales Value, 2019-2030
6.2.2 Key Countries/Regions Generic Sterile Injectable Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Generic Sterile Injectable Sales Value, 2019-2030
6.3.2 United States Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Generic Sterile Injectable Sales Value, 2019-2030
6.4.2 Europe Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Generic Sterile Injectable Sales Value, 2019-2030
6.5.2 China Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.5.3 China Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Generic Sterile Injectable Sales Value, 2019-2030
6.6.2 Japan Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Generic Sterile Injectable Sales Value, 2019-2030
6.7.2 South Korea Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Generic Sterile Injectable Sales Value, 2019-2030
6.8.2 Southeast Asia Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Generic Sterile Injectable Sales Value, 2019-2030
6.9.2 India Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.9.3 India Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 3M
7.1.1 3M Company Information
7.1.2 3M Introduction and Business Overview
7.1.3 3M Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.1.4 3M Generic Sterile Injectable Product Offerings
7.1.5 3M Recent Development
7.2 Baxter Inc
7.2.1 Baxter Inc Company Information
7.2.2 Baxter Inc Introduction and Business Overview
7.2.3 Baxter Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Inc Generic Sterile Injectable Product Offerings
7.2.5 Baxter Inc Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Introduction and Business Overview
7.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Fresenius Kabi Generic Sterile Injectable Product Offerings
7.3.5 Fresenius Kabi Recent Development
7.4 Pfizer/Hospira
7.4.1 Pfizer/Hospira Company Information
7.4.2 Pfizer/Hospira Introduction and Business Overview
7.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer/Hospira Generic Sterile Injectable Product Offerings
7.4.5 Pfizer/Hospira Recent Development
7.5 Novartis/Sandoz
7.5.1 Novartis/Sandoz Company Information
7.5.2 Novartis/Sandoz Introduction and Business Overview
7.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Novartis/Sandoz Generic Sterile Injectable Product Offerings
7.5.5 Novartis/Sandoz Recent Development
7.6 Teva
7.6.1 Teva Company Information
7.6.2 Teva Introduction and Business Overview
7.6.3 Teva Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Teva Generic Sterile Injectable Product Offerings
7.6.5 Teva Recent Development
7.7 Hikma
7.7.1 Hikma Company Information
7.7.2 Hikma Introduction and Business Overview
7.7.3 Hikma Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hikma Generic Sterile Injectable Product Offerings
7.7.5 Hikma Recent Development
7.8 Sun Pharma
7.8.1 Sun Pharma Company Information
7.8.2 Sun Pharma Introduction and Business Overview
7.8.3 Sun Pharma Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sun Pharma Generic Sterile Injectable Product Offerings
7.8.5 Sun Pharma Recent Development
7.9 Dr. Reddy’s
7.9.1 Dr. Reddy’s Company Information
7.9.2 Dr. Reddy’s Introduction and Business Overview
7.9.3 Dr. Reddy’s Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Dr. Reddy’s Generic Sterile Injectable Product Offerings
7.9.5 Dr. Reddy’s Recent Development
7.10 Mylan
7.10.1 Mylan Company Information
7.10.2 Mylan Introduction and Business Overview
7.10.3 Mylan Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Mylan Generic Sterile Injectable Product Offerings
7.10.5 Mylan Recent Development
7.11 AstraZeneca Plc
7.11.1 AstraZeneca Plc Company Information
7.11.2 AstraZeneca Plc Introduction and Business Overview
7.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.11.4 AstraZeneca Plc Generic Sterile Injectable Product Offerings
7.11.5 AstraZeneca Plc Recent Development
7.12 Merck & Co., Inc
7.12.1 Merck & Co., Inc Company Information
7.12.2 Merck & Co., Inc Introduction and Business Overview
7.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Merck & Co., Inc Generic Sterile Injectable Product Offerings
7.12.5 Merck & Co., Inc Recent Development
7.13 Hellberg Safety Ab
7.13.1 Hellberg Safety Ab Company Information
7.13.2 Hellberg Safety Ab Introduction and Business Overview
7.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Hellberg Safety Ab Generic Sterile Injectable Product Offerings
7.13.5 Hellberg Safety Ab Recent Development
8 Industry Chain Analysis
8.1 Generic Sterile Injectable Industrial Chain
8.2 Generic Sterile Injectable Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Generic Sterile Injectable Sales Model
8.5.2 Sales Channel
8.5.3 Generic Sterile Injectable Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Generic Sterile Injectable Market Trends
    Table 2. Generic Sterile Injectable Market Drivers & Opportunity
    Table 3. Generic Sterile Injectable Market Challenges
    Table 4. Generic Sterile Injectable Market Restraints
    Table 5. Global Generic Sterile Injectable Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Generic Sterile Injectable Revenue Market Share by Company (2019-2024)
    Table 7. Global Generic Sterile Injectable Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Generic Sterile Injectable Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Generic Sterile Injectable Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Generic Sterile Injectable Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Generic Sterile Injectable Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Generic Sterile Injectable
    Table 13. Global Generic Sterile Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Generic Sterile Injectable Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Generic Sterile Injectable Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Generic Sterile Injectable Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Generic Sterile Injectable Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Generic Sterile Injectable Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Generic Sterile Injectable Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Generic Sterile Injectable Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Generic Sterile Injectable Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Generic Sterile Injectable Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Generic Sterile Injectable Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Generic Sterile Injectable Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Generic Sterile Injectable Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Generic Sterile Injectable Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Generic Sterile Injectable Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Generic Sterile Injectable Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Generic Sterile Injectable Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Generic Sterile Injectable Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Generic Sterile Injectable Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Generic Sterile Injectable Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Generic Sterile Injectable Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Generic Sterile Injectable Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Generic Sterile Injectable Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Generic Sterile Injectable Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Generic Sterile Injectable Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Generic Sterile Injectable Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Generic Sterile Injectable Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Generic Sterile Injectable Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Generic Sterile Injectable Sales Value by Region (2019-2024) & (%)
    Table 44. Global Generic Sterile Injectable Sales Value by Region (2025-2030) & (%)
    Table 45. Global Generic Sterile Injectable Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Generic Sterile Injectable Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Generic Sterile Injectable Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Generic Sterile Injectable Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Generic Sterile Injectable Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Generic Sterile Injectable Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Generic Sterile Injectable Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Generic Sterile Injectable Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Generic Sterile Injectable Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Generic Sterile Injectable Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Generic Sterile Injectable Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Generic Sterile Injectable Sales Volume, (2025-2030) & (K Units)
    Table 57. 3M Company Information
    Table 58. 3M Introduction and Business Overview
    Table 59. 3M Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. 3M Generic Sterile Injectable Product Offerings
    Table 61. 3M Recent Development
    Table 62. Baxter Inc Company Information
    Table 63. Baxter Inc Introduction and Business Overview
    Table 64. Baxter Inc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Baxter Inc Generic Sterile Injectable Product Offerings
    Table 66. Baxter Inc Recent Development
    Table 67. Fresenius Kabi Company Information
    Table 68. Fresenius Kabi Introduction and Business Overview
    Table 69. Fresenius Kabi Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Fresenius Kabi Generic Sterile Injectable Product Offerings
    Table 71. Fresenius Kabi Recent Development
    Table 72. Pfizer/Hospira Company Information
    Table 73. Pfizer/Hospira Introduction and Business Overview
    Table 74. Pfizer/Hospira Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer/Hospira Generic Sterile Injectable Product Offerings
    Table 76. Pfizer/Hospira Recent Development
    Table 77. Novartis/Sandoz Company Information
    Table 78. Novartis/Sandoz Introduction and Business Overview
    Table 79. Novartis/Sandoz Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Novartis/Sandoz Generic Sterile Injectable Product Offerings
    Table 81. Novartis/Sandoz Recent Development
    Table 82. Teva Company Information
    Table 83. Teva Introduction and Business Overview
    Table 84. Teva Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Teva Generic Sterile Injectable Product Offerings
    Table 86. Teva Recent Development
    Table 87. Hikma Company Information
    Table 88. Hikma Introduction and Business Overview
    Table 89. Hikma Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Hikma Generic Sterile Injectable Product Offerings
    Table 91. Hikma Recent Development
    Table 92. Sun Pharma Company Information
    Table 93. Sun Pharma Introduction and Business Overview
    Table 94. Sun Pharma Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Sun Pharma Generic Sterile Injectable Product Offerings
    Table 96. Sun Pharma Recent Development
    Table 97. Dr. Reddy’s Company Information
    Table 98. Dr. Reddy’s Introduction and Business Overview
    Table 99. Dr. Reddy’s Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Dr. Reddy’s Generic Sterile Injectable Product Offerings
    Table 101. Dr. Reddy’s Recent Development
    Table 102. Mylan Company Information
    Table 103. Mylan Introduction and Business Overview
    Table 104. Mylan Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Mylan Generic Sterile Injectable Product Offerings
    Table 106. Mylan Recent Development
    Table 107. AstraZeneca Plc Company Information
    Table 108. AstraZeneca Plc Introduction and Business Overview
    Table 109. AstraZeneca Plc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. AstraZeneca Plc Generic Sterile Injectable Product Offerings
    Table 111. AstraZeneca Plc Recent Development
    Table 112. Merck & Co., Inc Company Information
    Table 113. Merck & Co., Inc Introduction and Business Overview
    Table 114. Merck & Co., Inc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Merck & Co., Inc Generic Sterile Injectable Product Offerings
    Table 116. Merck & Co., Inc Recent Development
    Table 117. Hellberg Safety Ab Company Information
    Table 118. Hellberg Safety Ab Introduction and Business Overview
    Table 119. Hellberg Safety Ab Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Hellberg Safety Ab Generic Sterile Injectable Product Offerings
    Table 121. Hellberg Safety Ab Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Generic Sterile Injectable Downstream Customers
    Table 125. Generic Sterile Injectable Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Generic Sterile Injectable Product Picture
    Figure 2. Global Generic Sterile Injectable Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Generic Sterile Injectable Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Generic Sterile Injectable Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Generic Sterile Injectable Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Generic Sterile Injectable Report Years Considered
    Figure 7. Global Generic Sterile Injectable Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Generic Sterile Injectable Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Generic Sterile Injectable Revenue in 2023
    Figure 10. Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Monoclonal Antibodies Picture
    Figure 12. Cytokines Picture
    Figure 13. Insulin Picture
    Figure 14. Peptide Hormones Picture
    Figure 15. Vaccines Picture
    Figure 16. Others Picture
    Figure 17. Global Generic Sterile Injectable Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Generic Sterile Injectable Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Generic Sterile Injectable Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Generic Sterile Injectable Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Generic Sterile Injectable Price by Type (2019-2030) & (USD/Unit)
    Figure 22. Product Picture of Hospitals
    Figure 23. Product Picture of Pharmacies
    Figure 24. Product Picture of Online Pharmacies
    Figure 25. Global Generic Sterile Injectable Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Generic Sterile Injectable Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Generic Sterile Injectable Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 28. Global Generic Sterile Injectable Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Generic Sterile Injectable Price by Application (2019-2030) & (USD/Unit)
    Figure 30. North America Generic Sterile Injectable Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Generic Sterile Injectable Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Generic Sterile Injectable Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Generic Sterile Injectable Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Generic Sterile Injectable Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Generic Sterile Injectable Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Generic Sterile Injectable Sales Volume (%), (2019-2030)
    Figure 42. United States Generic Sterile Injectable Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Generic Sterile Injectable Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Generic Sterile Injectable Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Generic Sterile Injectable Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Generic Sterile Injectable Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Generic Sterile Injectable Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Generic Sterile Injectable Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Generic Sterile Injectable Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Generic Sterile Injectable Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Generic Sterile Injectable Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Generic Sterile Injectable Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Generic Sterile Injectable Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Generic Sterile Injectable Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Generic Sterile Injectable Sales Value by Application (%), 2023 VS 2030
    Figure 63. Generic Sterile Injectable Industrial Chain
    Figure 64. Generic Sterile Injectable Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS